1-220074070-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_006085.6(BPNT1):c.122C>A(p.Thr41Asn) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000199 in 1,611,842 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006085.6 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BPNT1 | NM_006085.6 | c.122C>A | p.Thr41Asn | missense_variant, splice_region_variant | 3/9 | ENST00000322067.12 | NP_006076.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BPNT1 | ENST00000322067.12 | c.122C>A | p.Thr41Asn | missense_variant, splice_region_variant | 3/9 | 1 | NM_006085.6 | ENSP00000318852.7 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 247266Hom.: 0 AF XY: 0.0000373 AC XY: 5AN XY: 134010
GnomAD4 exome AF: 0.0000206 AC: 30AN: 1459680Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 14AN XY: 725956
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.122C>A (p.T41N) alteration is located in exon 3 (coding exon 2) of the BPNT1 gene. This alteration results from a C to A substitution at nucleotide position 122, causing the threonine (T) at amino acid position 41 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at